Study Finds HIV Prevention Gains Have Stalled in KwaZulu-Natal District

DURBAN, SOUTH AFRICA — As a study finds hiv prevention momentum has stalled across rural KwaZulu-Natal, public health experts and epidemiologists are calling for urgent re-evaluations of national prevention strategies. Research published in The Lancet HIV by Elphas Okango and colleagues from the Africa Health Research Institute (AHRI) reveals that after years of dramatic progress, the reduction in new HIV infections plateaued between 2019 and 2025 in the uMkhanyakude district.

The longitudinal study, which tracked tens of thousands of participants over two decades, indicates that while incidence previously dropped by 52% in males and 37% in females between 2013 and 2018, progress has since flattened—exacerbated by a 10% rise in detectable community viral load.

Longitudinal Tracking Data and Surveillance Metrics

Data compiled from The Lancet HIV publication, AHRI cohort tracking, and health sector editor analyses detail current epidemiological benchmarks:

Epidemiological & Prevention Category	Longitudinal Surveillance Benchmarks
Historical Incidence Decline (2013–2018)	52% drop in males; 37% drop in females
Recent Trend Benchmark (2019–2025)	Plateaued incidence across both adult men and women
Detectable Viraemia Increase	10% increase in people with detectable viral load
Estimated Lifetime Infection Risk	~1 in 2 for women; 3 in 10 for men in uMkhanyak

Why a Key Study Finds HIV Prevention Progress Plateauing

Understanding the epidemiological dynamics behind why the study finds hiv prevention gains flattening requires analyzing age demographic shifts and treatment adherence mechanisms:

• Shifting Demographic Incidence: While new HIV infections continued to fall among young adults, rising incidence among older adults offset those youth gains. Older cohorts often perceive themselves at lower risk and remain underserved by tailored prevention campaigns.

• Detectable Viral Viraemia and Undetectable = Untransmittable (U=U): A 10% rise in population detectable viral load expands the potential transmission pool. Effective antiretroviral therapy (ART) suppresses viral loads, rendering the virus sexually untransmittable; however, treatment interruptions, stock-outs, and missed diagnoses undermine this barrier.

• Reaching the Prevention Floor and Behavioral Decline: Early gains achieved by expanding universal ART coverage have largely peaked. Sustaining further declines becomes increasingly complex as ongoing transmission shifts toward harder-to-reach populations, compounded by reduced condom distribution.

Impact of Foreign Aid Reductions and Stagnant Treatment Numbers

The study arrives at a precarious juncture for South Africa’s public health infrastructure. U.S. foreign aid reductions under PEPFAR took effect last year, placing severe budgetary constraints on community outreach programmes. National data published in May 2026 confirmed that South Africa’s total antiretroviral treatment enrollment stalled in 2025, raising fears of a broader rebound in transmission.

However, commentators Marcus Low (Spotlight) and Nathan Geffen (GroundUp) noted that while the study is highly rigorous, data from a single district should not be generalized to the entire nation without further multi-province incidence research.

Reorienting Prevention Tools and Re-Engaging High-Risk Groups

Epidemiologists emphasize that the slowdown is not irreversible if health authorities pivot toward high-yield prevention tools, including long-acting pre-exposure prophylaxis (PrEP), expanded barrier contraception, and tailored outreach for older age cohorts.

Strengthening treatment retention and restoring community viral suppression remain critical to securing epidemic control as this study finds hiv prevention progress requiring refreshed policy leadership across South Africa.

Why It Matters: Stagnating HIV prevention amid falling international aid threatens to reverse two decades of progress, making targeted interventions for older adults and uninterrupted ART access essential to preventing an epidemic rebound.

 

 

 

Source: Spotlight / GroundUp Editorial, October , 2026